• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

E.NOVATION AND SENTILLION COOPERATE ON SINGLE SIGN-ON
Capelle aan den IJssel (the Netherlands) / Andover, MA (USA), 17 July 2008 - IT service provider E.Novation has entered into a partnership with the US healthcare identity and access management specialist Sentillion. The...

Boehringer Ingelheim licenses drug targets from autoimmune collaboration with Galapagos
Mechelen, Belgium; 17 July 2008 - Galapagos NV (Euronext: GLPG) announced today that Boehringer Ingelheim has exercised its right to license two drug targets from the autoimmune research agreement with Galapagos'...

ANGEL BIOTECHNOLOGY HOLDINGS PLC (Angel or the Company)
July 17, 2008-Angel Biotechnology Holdings plc, (AIM: ABH) the biopharmaceutical contract manufacturer, is pleased to announce that it has received a milestone payment from ACE Biosciences A/S (www.acebiosciences.com)...

Advanced Life Sciences Announces Collaboration With UK Ministry of Defence on ALS-886
CHICAGO, July 17-- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced that the United Kingdom's Defence Science and Technology Laboratory ("Dstl") will evaluate the developmental compound ALS-886 as a...

Hutchinson Center receives $7.6 million federal grant to study how genetic variations influence risk of common diseases
SEATTLE -- July 17, 2008 -- Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and...

Zila to Begin Distributing Its Proprietary Oral Cancer Screening Product, ViziLite Plus, in Greece
PHOENIX--July 17, 2008--Zila, Inc. (NASDAQ:ZILA) today announced that it has selected Intertrade Dental A.E.S.A. to be the exclusive distributor of ViziLite(R) Plus with TBlue(TM), Zila's proprietary oral cancer...

Ipsen completes purchase of all of OBI-1 assets from Octagen Corporation
Paris (France), 17 July 2008 - Ipsen (Euronext: IPN) today announced that, following the announcement made on June 5, 2008 and the shareholder approval of Octagen Corporation, it has completed the purchase of all of the...

Thermo Fisher Scientific Acquires Affinity BioReagents
WALTHAM, Mass.--July 17, 2008--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has acquired Affinity BioReagents, a leading provider of antibodies, peptides,...

Hologic, Inc. Accepts Shares Of Third Wave Technologies, Inc. In Tender Offer And Commences Subsequent Offering Period
BEDFORD, Mass. and Madison, WI, (July 17, 2008) - Hologic, Inc. (Nasdaq: HOLX) and Third Wave Technologies, Inc. (NASDAQ: TWTI) ("Third Wave"), today jointly announced the expiration of the initial offering period of...

Boehringer Ingelheim licenses drug targets from autoimmune collaboration with BioFocus DPI
July 17, 2008--BioFocus DPI announced today that Boehringer Ingelheim has exercised its right to license two drug targets from its autoimmune research agreement, resulting in a milestone payment to BioFocus DPI.

MacroGenics Acquires Raven Biotechnologies
Rockville, Maryland. July 17, 2008. MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the...

Sanofi-aventis signs a collaboration agreement with The Johns Hopkins University School of Medicine to find new therapies for respiratory & immuno-allergic diseases
Paris, France, July 17, 2008 - Sanofi-aventis announced today that it has signed a three year agreement with the Division of Allergy and Clinical Immunology (ACI) of The Johns Hopkins University School of Medicine,...

3M Health Care and Greystone Pharmaceuticals, Inc. Announce License Agreement for Innovative Wound Care Technology
ST. PAUL, Minn.--July 17, 2008-3M Health Care and Greystone Pharmaceuticals, Inc. today announce they have entered into an exclusive, worldwide license agreement for wound care products using Greystone's patented PHI...

BELLUS Health announces closing of Innodia acquisition
LAVAL, QC, July 17, 2008 - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today the closing of the acquisition of Innodia Inc. that it had previously announced on July 16, 2008.

Medtronic Completes Acquisition of Restore Medical
MINNEAPOLIS - July 17, 2008 - Medtronic, Inc. (NYSE:MDT) today announced that it has completed its acquisition of Restore Medical, Inc. (NASDAQ: REST). Under the terms of the agreement announced on April 22, 2008,...

MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)
Martinsried/ Munich, July 17, 2008. MediGene AG (Frankfurt, Prime Standard: MDG) announced that, according to plan, an option, granted two years ago by the German Cancer Research Center (Deutsches Krebsforschungszentrum...

First AbD Serotec generated HuCAL Antibodies Distributed as Part of Clinical Diagnostic Kits for Autoimmune Diseases by Phadia
July 17, 2008 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that Phadia AB, a world leader in autoimmunity and allergy testing, has implemented a series of HuCAL-based recombinant antibodies...

DAIICHI SANKYO AND RANBAXY CONFIRM DEAL IS BINDING AND FINAL ALLAY MARKET RUMOUR AND SPECULATION
Gurgaon, India, July 17, 2008 -- Following intense speculation in sections of the media and the stock market, Daiichi Sankyo Company, Limited (Daiichi Sankyo) and Ranbaxy Laboratories Limited (Ranbaxy) reiterate that...

Exclusive Evaluation Agreement Signed with MedImmune
July 16, 2008 -- Norwood Immunology Limited and its subsidiaries ('Norwood Immunology' or 'the Group') (AIM:NIM), the Group focused on stem cell therapies, the rejuvenation and repair of the immune system and the...

IRIS RECEIVES ORDER FOR SEVEN iQ®200 URINE ANALYZERS FOR KUWAIT MINISTRY OF HEALTH
CHATSWORTH, CA, July 16, 2008 - IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today...

Siemens and NCR Ink Reseller Agreement
DAYTON, Ohio., and MALVERN, Pa., July 16, 2008 - Siemens Healthcare (www.usa.siemens.com/healthcareit) and NCR Corporation (NYSE: NCR) are collaborating to offer NCR MediKiosk(TM) solutions to the Siemens customer base...

Omnicare Acquires Advanced Care Scripts, Inc.
COVINGTON, Ky., July 16, 2008 -- Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly, today announced the acquisition of specialty pharmaceutical services provider,...

BELLUS Health signs agreement to acquire Innodia
LAVAL, QC, July 16, 2008 - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today that it has signed a definitive agreement to purchase capital stock of Innodia Inc. This will...

Misonix Announces New Distribution Agreement for Sonablate(R) in the Russian Federation
FARMINGDALE, N.Y., July 16, 2008 -- Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute...

Cardinal Health Signs Agreement with Premier for Custom Procedure Packs, Surgical Drapes and Apparel, Bringing Members Additional Value
DUBLIN, Ohio, July 16, 2008 - Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced that it has signed an agreement to offer Presource®...

BIOWA AND MEDAREX ANNOUNCE LICENSE OF BIOWA'S COMPLEGENT(TM) TECHNOLOGY
Princeton, NJ, USA, July 16, 2008 - BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first everaccess to BioWa's COMPLEGENT(TM)...

Symphogen and Biovitrum have Initiated a Novel Treatment Study in Autoimmune Bleeding Disorder (ITP) Patients
COPENHAGEN, Denmark and STOCKHOLM, Sweden- July 16, 2008. Symphogen A/S and Biovitrum AB (publ) (STO:BVT) today announced the recruitment of the first patient into a Phase II clinical trial, initiated in June, to...

U. S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor
Woburn, MA July 16, 2008 -- U.S. Genomics today announced the award of a $9.1 million contract by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate. The Phase IIIX contract under the...

Theragenics Agrees to Acquire NeedleTech Products for $47.8 Million
BUFORD, Ga. -- July 16, 2008 -- Theragenics Corporation(R) (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, announced today that it has signed an agreement to...

TGen Awarded $1.99 Million Grant to Advance Highly Parallel Supercomputing
Phoenix, Arizona, July 16, 2008 -- The National Institutes of Health (NIH) today awarded a $1.99 million grant to the Translational Genomics Research Institute (TGen) to enhance its supercomputing capabilities. The...

Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis
CAMBRIDGE, Mass., Jul 16, 2008 -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that Novartis has elected to extend the company's RNAi therapeutics collaboration for...

BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology
PRINCETON, N.J., July 16, 2008 -- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first ever access to BioWa's COMPLEGENT(TM)...

Dow and NREL Partner to Convert Biomass to Ethanol and Other Chemical Building Blocks
Midland, MI and Golden, Colo. - July 16, 2008--The Dow Chemical Company (Dow) and the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) today announced an agreement to jointly develop and evaluate...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
Novato, California, July 16, 2008 - Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement (the "Agreement") with the University...

Pediatrix Acquires Atlanta Maternal-Fetal Physician Practice
FORT LAUDERDALE, Fla. -- July 16, 2008 -- Pediatrix Medical Group, Inc. (NYSE:PDX) has acquired Maternal Fetal Diagnostic Center of Atlanta, Inc., a physician group that provides services to women with complicated...

SGS Acquires a 50% Stake in Bluesign Technologies Group
July 16, 2008 -- SGS is pleased to announce that it has acquired a 50% shareholding in Bluesign Technologies Group, a St. Gallen (Switzerland) based company specialising in the management of Environment, Health and...

McKesson Acquisition of EN-Chart Enhances Emergency Care Solutions
July 16, 2008 -- ATLANTA-- McKesson today announced it has acquired EN-Chart Scanning Program, LLC, a market-leading provider of computer-assisted facility coding and compliance solutions for emergency department (ED)...

Healthvision Acquires MediSolution's Healthcare Products and Services Division
DALLAS - July 16, 2008 - Healthvision today entered into a definitive agreement to purchase the majority of MediSolution's Healthcare Products & Services Division's assets, a leading healthcare technology provider...

METABOLON EXPANDS PARTNERSHIP WITH MITSUBISHI TANABE
RESEARCH TRIANGLE PARK, NC. (July 15, 2008) --Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today the continuation and expansion of a multi-study agreement with...

Veeda Clinical Research selects Watson LIMS
PHILADELPHIA, Penn., JULY 15, 2008 - Thermo Fisher Scientific Inc., the world leader in serving science, announced today that Veeda Clinical Research has selected its Thermo Scientific Watson LIMS TM to automate its...

Pfizer Inks Global License to Genomatix Software and Databases
Ann Arbor, MI - July 15, 2008 - Genomatix Software, Inc. the US branch of Munich (Germany) based Genomatix Software GmbH, announced that it has reached an agreement with Pfizer Pharmaceuticals to provide Genomatix...

Pfizer Inks Global License to Genomatix Software and Databases
Ann Arbor, MI - July 15, 2008 - Genomatix Software, Inc. the US branch of Munich (Germany) based Genomatix Software GmbH, announced that it has reached an agreement with Pfizer Pharmaceuticals to provide Genomatix...

VIVALIS AND INTERVET SCHERING PLOUGH ANIMAL HEALTH SIGN A LETTER OF INTENT FOR A COMMERCIAL LICENSE TO USE EBx® CELL LINE FOR A VIRAL VACCINE PRODUCTION
Nantes, France, July 15th, 2008- VIVALIS (NYSE Euronext :VLS) and INTERVET/SCHERING-PLOUGH ANIMAL HEALTH announced today that they have signed a letter of intent for a commercial license related to the avian embryonic...

Power3 Medical Products and the Princess Haya Biotechnology Center, Jordan University of Science and Technology, Collaborate in a Clinical Validation Study of the BC-SeraPro(TM) Breast Cancer Diagnostic Blood Test
HOUSTON -- July 15, 2008 -- Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for breast cancer and...

Pharming Signs Commercialization Agreement For Lactoferrin With Aslan Group A.S
Leiden, The Netherlands, July 15, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that it has signed a commercialization and supply agreement with Aslan Group...

NeuroHealing Pharmaceuticals Receives Grant from the FDA Office of Orphan Drugs for Clinical Development of NH001 to Treat Patients in a Vegetative and Minimally Conscious State
Newton, Massachusetts - July 15, 2008 - NeuroHealing Pharmaceuticals, a company developing products for individuals with chronic brain injuries, today announced that the Food and Drug Administration (FDA) has awarded...

Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
Madison, N.J., July 15, 2008 -- Wyeth Consumer Healthcare, a division of Wyeth (NYSE: WYE), announced today that it has signed an agreement to purchase ThermaCareâ, a leading over-the-counter heat wrap, from Procter &...

Medicago to evaluate establishment of a pandemic vaccine production facility in France in collaboration with Genopole d'Evry in ParisMT
Quebec City, Quebec, July 15, 2008 -- Medicago Inc. (TSX-V: MDG) today announced that it will conduct a feasibility study in collaboration with Genopole biopark, in Evry, for the establishment of a vaccine production...

Lumera Completes Device Shipment on Third Order from Lockheed Martin
BOTHELL, Wash.-- July 15, 2008--Lumera Corporation (NASDAQ:LMRA), a leader in the field of photonics communication, announced today that it has completed the shipment of electro-optic devices on the third purchase order...

Dyax Enters into an Exclusive Negotiation Period with Dompe for European License to DX-88 in Angioedema Indications
CAMBRIDGE, Mass., Jul 15, 2008 -- Dyax Corp. (NASDAQ: DYAX) announced today that the Company has entered into an exclusive negotiation period ending on September 30, 2008 with Dompe Farmaceutici S.p.A. ("Dompe") for a...

ViroPharma To Acquire Lev Pharmaceuticals
EXTON, Pa., July 15, 2008 -- ViroPharma Incorporated (Nasdaq: VPHM) and Lev Pharmaceuticals, Inc. (OTC Bulletin Board: LEVP) today announced that the companies have signed a definitive merger agreement under which...

Lonza and Kyowa Hakko extend their strategic collaboration
July 15, 2008 -- Lonza and Kyowa Hakko Kogyo Co., Ltd. announce an agreement today whereby Lonza will license to Kyowa Hakko and its US subsidiary BioWa Inc. (Kyowa Hakko Group) its GS Gene Expression System(TM) (GS:...

DOR BioPharma Enters into Collaborative Agreement with IDIS for Named Patient Access of orBec® in Europe
Ewing, NJ - July 15, 2008 - DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat the life-threatening side effects of cancer treatments, serious...

Dow and PIC of Kuwait Continue Progress on Proposed $11B Joint Venture
Midland, MI and Kuwait City, Kuwait - July 15, 2008--The Dow Chemical Company (NYSE: DOW) and Petrochemical Industries Company (PIC) of the State of Kuwait, a wholly owned subsidiary of Kuwait Petroleum Corporation...

ViroPharma to Acquire Lev Pharmacueticals
EXTON, Pa., July 15, 2008 -- ViroPharma Incorporated (Nasdaq: VPHM) and Lev Pharmaceuticals, Inc. (OTCBB: LEVP) today announced that the companies have signed a definitive merger agreement under which ViroPharma will...

Lonza and Kyowa Hakko extend their strategic collaboration
Basel, CH & Tokyo, Japan, 15 July 2008 - Lonza Group Ltd and Kyowa Hakko Kogyo Co., Ltd. announce today an agreement, whereby Lonza will license to Kyowa Hakko and its US subsidiary BioWa Inc. (Kyowa Hakko Group) its GS...

University of Maryland Baltimore Licenses XRAY Excel Array Analysis
Reno, NV, July 15, 2008 - Biotique Systems announced today that it has licensed XRAY Excel Array Analysis software to University of Maryland Baltimore. XRAY is a gene expression analysis system for analyzing Affymetrix...

NEOPROBE SIGNS NON-BINDING LETTER OF INTENT FOR LYMPHOSEEK EUROPEAN DISTRIBUTION
DUBLIN, OHIO - July 15, 2008 - Neoprobe Corporation (OTCBB:NEOP - News), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that Neoprobe and DRAXIMAGE, a...

MorphoSys and Integrated BioTherapeutics Provide Update Regarding USAMRIID Biodefense Project
July 15, 2008--AbD Serotec, a division of MorphoSys AG, announced today that its customer, US-based Integrated BioTherapeutics Inc. (IBT), has received a five-year, NIH research grant to develop human antibody...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
AMSTERDAM, The Netherlands, July 15 -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research...

PURE Bioscience Announces Distribution Agreement with Orchem Corporation
SAN DIEGO, Calif., July 15, 2008 - PURE Bioscience (NASDAQ: PURE) today announced an agreement with Orchem Corporation for distribution of PURE's silver dihydrogen citrate (SDC)-based disinfectant under Orchem's...

Perlegen Sciences Out-Licenses Intellectual Property for Genetic Diagnostics
Mountain View, CA -- July 15, 2008 -- Perlegen Sciences, Inc., a molecular diagnostics company focused on the discovery and commercialization of clinically important human genetic variation, announced today the opening...

Allergan Completes Acquisition of Aczone Gel 5%
IRVINE, Calif., Jul 14, 2008 -- Allergan, Inc.'s (NYSE:AGN) wholly-owned subsidiary, Allergan Sales, LLC, and QLT USA, Inc., a wholly-owned subsidiary of QLT Inc. (NASDAQ:QLTI) (TSX:QLT) today announced the completion...

Jubilant in Drug Discovery partnership with Amgen Inc, USA
July 14, 2008 -- Jubilant Biosys Ltd., Bangalore, the India based subsidiary of Jubilant Organosys Ltd,New Delhi, India and Amgen Inc, Thousand Oaks, California, the largest US based Biotech company, today announced a...

Sun Pharma Extends Tender Offer for Taro
Mumbai, India: July 14, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd....

MRC Technology and Biolex Therapeutics Successfully Complete Collaboration to Humanize a Novel Antibody Targeting CD20
London, UK, and Pittsboro, North Carolina, USA, July 14, 2008 - MRC Technology (MRCT) (London, UK) and Biolex Therapeutics, Inc. (Pittsboro, North Carolina, USA) announced today that MRCT had successfully completed the...

TOSHIBA AMERICA MEDICAL SYSTEMS AWARDED CT GROUP BUY AGREEMENT FROM BROADLANE
TUSTIN, California July -- 14, 2008 -- Toshiba America Medical Systems, Inc. was awarded a computed tomography (CT) contract by Broadlane's clients. Toshiba, an industry leader in CT technology, has won this contract...

PDL Biosciences Licenses XRAY Excel Array Analysis
Reno, NV, July 14, 2008 - Biotique Systems announced today that it has licensed XRAY Excel Array Analysis software to PDL Biosciences. XRAY is a gene expression analysis system for analyzing Affymetrix Microarrays.

Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider
GAITHERSBURG, MD and SANTA CLARA, Calif., July 14, 2008 --Gene Logic (An Ocimum Biosolutions Company) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service...

Nycomed adds veltuzumab for autoimmune diseases to R&D pipeline
July 14, 2008 -- Nycomed and Immunomedics today announced a collaboration and licensing agreement on Immunomedics' veltuzumab. Under the agreement, Nycomed will receive the exclusive, worldwide rights to develop,...

NBTY Closes on Purchase of Leiner Health Products
RONKONKOMA, N.Y., July 14, 2008 -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it has completed the purchase of substantially all of...

CSC'S DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit
FALLS CHURCH, Va., July 14 - CSC (NYSE: CSC) announced today that DynPort Vaccine Company LLC (DVC), a CSC company, has received a contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of...

Compumedics Joins Germany's High-Tech Élite
july 14, 2008--Leading Australia-based medical devices company, Compumedics Limited (ASX: CMP), today announced that its wholly owned Germany subsidiary, Compumedics Germany GmbH, has joined Germany's high-technology...

M. D. Anderson Announces Collaboration with the Chinese University of Hong Kong
July 14, 2008 -- The University of Texas M. D. Anderson Cancer Center today signed a sister institution agreement with the Sir Y.K. Pao Centre for Cancer and Hong Kong Cancer Institute at the Chinese University of Hong...

Luminex Corporation and ViroNovative Announce License Agreement for Human Metapneumovirus Rights
AUSTIN, Texas & ROTTERDAM, Netherlands, July 14, 2008 -- Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, and ViroNovative BV today announced that the companies have signed a licensing...

Notice Concerning the Determination of the Items of Stock Options (Stock Acquisition Rights) for Members of the Board of Directors
Osaka, Japan, July 14, 2008 --- Takeda Pharmaceutical Company Limited ("the Company") announced today that the amount to be paid in exchange for Stock Acquisition Rights to be granted to its Directors and other related...

SurModics and Brookwood License Nanotechnology Drug Delivery System
EDEN PRAIRIE, Minnesota - July 14, 2008 - SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood...

SurModics and Brookwood License Nanotechnology Drug Delivery System
EDEN PRAIRIE, Minn. -- July 14, 2008 -- SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood...

ZEBET, BASF, and Transinsight collaborate to form a new in vitro search engine and knowledge base
July 14, 2008 -- BASF SE and Transinsight GmbH, a provider of semantic search technologies for Web 2.0, have agreed to establish close cooperation in the area of semantic analyses to search for alternatives to animal...

Hemispherx Biopharma, Inc. Announces Settlement of All Bioclones/Ribotech Litigation
Philadelphia, PA, Monday, July 14, 2008: Hemispherx Biopharma, Inc. (AMEX:HEB - News) today announced that all outstanding legal issues between Hemispherx and Bioclones (Proprietary), Ltd. and Ribotech (Pty) Ltd have...

GlaxoSmithKline and Actelion enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond
Monday 14 July 2008, London, UK & Allschwil, Switzerland -- GlaxoSmithKline (GSK) and Actelion Ltd (SWX: ATLN) announced today that they have entered into an exclusive worldwide collaboration (excluding Japan) for...

Gene Logic Renews Agreement with Agilent Technologies as Certified Service Provider
GAITHERSBURG, MD and SANTA CLARA, Calif., July 14, 2008--Gene Logic (An Ocimum Biosolutions Company) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service...

Gamida Cell Signs Collaboration Agreement with BDS
Jerusalem, Israel, July 14, 2008 --- Gamida Cell Ltd. announced today a collaboration agreement with Biologics Delivery Systems Group, Cordis Corporation. Under the terms of the agreement, Biologics Delivery Systems...

Physiomics Technology in continued and expanded support of Lilly's Oncology Programs
July 14, 2008 -- Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a further agreement with Eli Lilly and Company ('Lilly') (NYSE: LLY), the global...

JT's UK Subsidiaries Reach Resolution Agreement with OFT
Tokyo, July 12, 2008 - Japan Tobacco Inc. ("JT") (TSE: 2914) announced today that Gallaher Group Ltd. and Gallaher Ltd. (together referred to as "Gallaher"), JT's tobacco subsidiaries in the United Kingdom, have...

Emageon Selected by HealthNet L.L.C.
BIRMINGHAM, Ala., July 11, 2008 -- Emageon Inc. (Nasdaq: EMAG), a leading provider of technology solutions for hospitals and healthcare networks announced today that the company's RadSuite product has been chosen by...

REG-Avacta Group plc: Customer Agreement
July 11, 2008--Delivery of prototype mobile chemical detection system to MOD Porton Down Avacta Group plc ("Avacta"), which develops detection and analysis technology aimed at the pharmaceutical, diagnostics and defence...

IOMAI Acquisition granted clearance by US Authorities
Vienna (Austria), July 11, 2008 - Intercell AG today announced that, following review by the United States Securities and Exchange Commission (SEC), Iomai Corporation filed a definitive proxy statement on July 10, 2008...

Fusion Antibodies announces antibody research agreement with Antitope
July 11, 2008 -- Fusion Antibodies Ltd. collaborate with Antitope to generate non-immunogenic antibody therapeutics.

Signalife Board Approves Merger
LOS ANGELES and LONDON, July 11, 2008 -- Signalife, Inc. (Amex: SGN - News) announced that it has received board approval to proceed with its previously-announced merger or similar business combination with Heart One...

Publication of Sanofi-Aventis Europe's Offer of CzK 1,050 in cash per Share for Zentiva NV
Paris, France - July 11, 2008 - Sanofi-aventis announces the opening today of the Offer by its wholly-owned subsidiary Sanofi-Aventis Europe to acquire all issued ordinary shares (including shares held in the form of...

Statement regarding Official Publication of Voluntary Takeover Offer by Sanofi Aventis Europe
Prague, London, July 11, 2008 - Zentiva N.V. notes the official publication today by Sanofi Aventis Europe, a wholly owned subsidiary of sanofi-aventis, of its unsolicited voluntary takeover offer to acquire Zentiva...

New strategic partnership strengthens Lonza's position as leading supplier to the life science industry
Basel, 11 July 2008 - Novartis and Lonza have entered into a long term strategic partnership for the joint development and manufacture of the Novartis biological pipeline. Lonza will contribute its biotech leadership...

New Distributor for Syngene Image Analysis Products Guarantees a High Level of Support and Service for Researchers in Greece
July 11, 2008 -- Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce it has appointed long established life science reagent and equipment supplier, Varelas S.A. as...

Invitrogen to Integrate Brendan Technologies' Advanced Analytical Software into Protein Analysis Solutions
CARLSBAD, Calif -- July 11, 2008--Invitrogen Corporation (NASDAQ:IVGN), a leading provider of essential life sciences technologies for research, production and diagnostics, announced today it has entered into an...

Novartis enters strategic partnership with Lonza to accelerate growth of biologics pipeline
Basel, July 11, 2008 - Novartis today announced a unique and flexible long-term partnership with Lonza, a global biotech leader in process development and manufacturing, to rapidly scale up technical development and...

DSM acquires Valley Research to strengthen food enzymes activities
Heerlen,NL,11-Jul-2008--Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the acquisition of the business and substantially all of the assets of...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us